A 37-year-old man with alcoholic pancreatitis complicated by pancreatic pseudocyst underwent endoscopic cystgastrostomy with an AXIOS 15-mm lumen-apposing metal stent (Boston Scientific, Marlborough, Mass) ( Fig. 1A and B) . Seven weeks later the patient was hospitalized because of hematemesis and melena. The patient had a baseline hemoglobin of 11.1 g/dL, which acutely declined to 9.1 g/dL. CT angiography did not show a bleeding source but did reveal complete cyst resolution. An EGD revealed a blood clot in the cystgastrostomy stent with active blood oozing through the stent (Video 1, available online at www.VideoGIE.org). Further examination revealed active oozing from the pancreatic cyst bed (Fig. 1C) . Endoscopic placement of Surgicel oxidized regenerated cellulose (Ethicon, Somerville, NJ) through the endoscope was applied to the bleeding cyst bed (Fig. 1D) . The Surgicel was placed using biopsy forceps. Fifteen milliliters of 5000 units of Recothrom recombinant topical thrombin (ZymoGenetics, Seattle, Wash) was applied by use of a Tandem catheter (Boston Scientific) over the Surgicel, and complete hemostasis was achieved (Fig. 1E) . Examination of the pancreatic cyst bed through the cystgastrostomy stent was repeated 48 hours later and showed no further evidence or stigmata of bleeding (Fig. 1F) . At a 4-week follow-up visit, the patient's hemoglobin had improved to 12 g/dL without evidence of further bleeding, and he underwent endoscopic AXIOS stent removal (Fig. 1G) .
Bleeding after endoscopic cystgastrostomy is a known adverse event, usually treated with angiography and embolization or coiling. We describe a new method that is potentially effective for endoscopic treatment of postcystgastrostomy bleeding that was not identified by angiography. Our patient had venous bleeding from the pancreatic cyst bed that was safely treated with the above-described method. 
